Edwards Lifesciences | EW - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
Artivion USD 106.93M 14.23M 2026-06
AtriCure USD 81.92M 8.72M 2026-06
Baxter International USD 3.81B 218M 2026-09
Becton, Dickinson and Co. USD 9.4B 897M 2026-06
Boston Scientific USD 6.43B 1.86B 2026-06
Cooper Companies USD 1.87B 61.9M 2026-06
Dexcom USD 2.25B 105.1M 2026-09
Edwards Lifesciences USD 1.51B 98.9M 2026-06
Globus Medical USD 479.35M 3.12M 2026-06
ICU Medical USD 498.36M 19.54M 2026-06
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 744.2M 56.7M 2026-06
Integra LifeSciences USD 329M 1.88M 2026-09
Intuitive Surgical USD 3.23B 652.4M 2026-09
J&J USD 55.46B 562M 2026-09
Medtronic USD 11.8B 141M 2026-06
Merit Medical Systems USD 265.08M 150K 2026-09
Stryker USD 6.5B 184M 2026-09
Tandem Diabetes Care USD 253M 5.05M 2026-06
Teleflex USD 720.38M 7.67M 2026-06
Zimmer Biomet Holdings USD 3.01B 149.2M 2026-06